A Study of 99m Tc Pertechnetate Produced in High Energy Cyclotron in Patients With Thyroid Scan Indication
NCT02307175 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30
Last updated 2017-12-04
Summary
Prospective, open label single site study to demonstrate the safety and efficacy of Tc-99m pertechnetate produced by high energy cyclotron at CHUS.
Conditions
- Autoimmune Thyroid Disease
- Congenital Hypothyroidism
Sponsors & Collaborators
-
Centre de recherche du Centre hospitalier universitaire de Sherbrooke
lead OTHER
Principal Investigators
-
Eric Turcotte, MD · Centre de recherche du Centre hospitalier universitaire de Sherbrooke
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-09-01
- Primary Completion
- 2016-08-31
- Completion
- 2016-10-31
Countries
- Canada
Study Locations
More Related Trials
-
The Use of 124-I-PET/CT Whole Body and Lesional Dosimetry in Differentiated Thyroid Cancer
NCT03841617 ·Status: RECRUITING ·Phase: PHASE2
-
Diagnostic Accuracy Study of Indocyanine Green for Parathyroid Perfusion Assessment
NCT03969108 ·Status: COMPLETED ·Phase: PHASE4
-
Pediatric Risk of Hypothyroidism With Iodinated Contrast Media
NCT03631771 ·Status: WITHDRAWN ·Phase: PHASE4
-
Validation of a New TSH Test
NCT01997554 ·Status: COMPLETED ·Phase: NA
-
Evaluation Study of L-T3 Utility in the Follow-up of Patients With Thyroid Cancer
NCT00223158 ·Status: COMPLETED ·Phase: NA
-
Effects of Levothyroxine Supplementation in Patients With Systolic Heart Failure and Subclinical Hypothyroidism
NCT02316743 ·Status: UNKNOWN ·Phase: PHASE4
-
99mTc Sestamibi Scans In Thyroglobulin Positive Scan Negative Differentiated Thyroid Cancer (DTC) Patients
NCT03065218 ·Status: TERMINATED ·Phase: PHASE4
-
PET-TC in Thyroid Evaluation
NCT06852144 ·Status: ENROLLING_BY_INVITATION
-
Recombinant Thyrotropin PET-CT Fusion Scanning in Thyroid Cancer
NCT00181168 ·Status: COMPLETED ·Phase: PHASE2
-
Pilot 99mTechnetium-MIBI Single Photon Emission Computed Tomography - Computed Tomography (SPECT-CT) in Papillary Carcinoma (CA) Thyroid
NCT00984191 ·Status: UNKNOWN ·Phase: NA
-
The Role of an Optical Probe in Thyroid Cancer Diagnosis: Pilot Study
NCT01792492 ·Status: COMPLETED
-
PET Evaluation of Recurrent Differentiated Thyroid Cancer
NCT01641679 ·Status: UNKNOWN
-
rhTSH, Radioiodine Uptake and Goiter Reduction Following 131I Therapy in Patients With Benign Nontoxic Nodular Goiter
NCT00275171 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of the Efficacy and Safety of Levothyroxine in Brain Death Organ Donors: a Randomized Controled Trial
NCT02211053 ·Status: TERMINATED ·Phase: PHASE4
-
Effect of T4-T3 Combination Therapy Versus T4 Monotherapy in Patients With Hypothyroidism
NCT00531713 ·Status: COMPLETED ·Phase: PHASE4
-
Mechanistic Study of Subclinical Hypothyroidism In the Elderly
NCT02399475 ·Status: COMPLETED ·Phase: NA
-
Iodinated Contrast Agents and Risk of Hypothyroidism in Young Children in the United States
NCT02959827 ·Status: COMPLETED
-
Scientific Protocol for the Study of Thyroid Cancer and Other Thyroid Disease in Ukraine Following the Chernobyl Accident
NCT00341094 ·Status: COMPLETED
-
Hypothyroidism Treated With Calcitonin
NCT03342001 ·Status: COMPLETED ·Phase: PHASE4
-
ImmunoTEP for Patients With Medullary Thyroid Carcinoma.
NCT01730638 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Effect of Age, Weight and Sex on Levothyroxine Pharmacokinetics
NCT03102177 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Study of Radioiodine (131-I) Uptake Following Administration of Thyrogen and Hypothyroid States During Thyroid Hormone Withdrawal.
NCT00001730 ·Status: COMPLETED ·Phase: PHASE4
-
Metabolomics of Thyroid Hormones
NCT03823859 ·Status: COMPLETED
-
Testing a Web-based Intervention for Radioactive Iodine Symptom Management to Improve Health-related Quality of Life Among Differentiated Thyroid Cancer Patients
NCT06853925 ·Status: RECRUITING ·Phase: NA
-
Therapeutic Plasma Exchange in Thyrotoxicosis
NCT04485975 ·Status: COMPLETED